Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Reexamination Certificate
2007-12-19
2010-10-05
Huynh, Phuong (Department: 1644)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
C424S169100, C424S181100, C424S193100, C424S194100, C424S195110, C514S015800, C514S016700, C530S329000, C530S391100
Reexamination Certificate
active
07807134
ABSTRACT:
Described is a multi drug multiligand conjugate for targeted drug delivery. The MDML conjugate contains a plurality of tripartite molecules linked to a central scaffold moiety, with each tripartite molecule comprising a targeting molecule, a therapeutic agent and a scaffold binding element. The MDML conjugate allows for more efficient delivery of therapeutic agents to the cells resulting in enhanced therapeutic efficiency. A model MDL conjugate is disclosed as well as method for the synthesis of the model conjugate.
REFERENCES:
patent: 4863713 (1989-09-01), Goodwin et al.
patent: 5698178 (1997-12-01), Goldenberg
patent: 5976535 (1999-11-01), Fritzberg et al.
patent: 6191290 (2001-02-01), Safavy
patent: 6200546 (2001-03-01), Hoffman
patent: 6287536 (2001-09-01), Reno et al.
patent: 6436386 (2002-08-01), Roberts et al.
patent: 98/47524 (1998-10-01), None
patent: 00/78359 (2000-12-01), None
Dermer et al, Bio/Technology 12: 320, 1994.
Gura et al, Science 278: 1041-1042, Nov. 1997.
Pardridge et al, Combined Use of Carboxyl-Directed Protein Pegylation and Vector-Mediated Blood-Brain Barrier Drug Delivery System Optimizes Brain Uptake of Brain-Derived Neurotrophic Factor Following Intravenous Administration, Pharmaceutical Research 15(4): 576-582, 1998, Plenum Publishing Corporation.
Nathan et al, Copolymers of Lysine and Polyethylene Glycol: A New Family of Functionalized Drug Carriers, Bioconjugate Chem. 4(1): 54-62, Jan.-Feb. 1993, American Chemical Society .
Safavy, A. et al, Paclitaxel Derivatives for Targeted Therapy of Cancer; Toward the Development of Smart Texans, Journal of Medicine Chemistry, 1999, vol. 42, No. 23 : 4919-4924.
Safavy, A. et al, Synthesis of Bombesin Analogues for Radiolabeling with Rhenium-188. Cancer. 1997, vol. 18, No. 12: 2354-2359.
Safavy, A et al, Synthesis Cytotoxicity Evaluation, and Biodistribution Studies of a Novel Paclitasxes-MAb C225 Conjugate, Cancer Biotherapy and Radiopharmaceuticals, 2000, Abstract 8.
Deguchi et al, Retention of Biologic Activity of Human Epidermal Growth Factor Following conjugation to a Blood-Brain Barrier Drug Delivery Vector via an Extended Poly(ethylene glycol) Linker; Bioconjugate Chem 10: 32-37, Jan.-Feb. 1999.
Stryer et al, Biochemistry, Third edition, W H Freeman Company, New York, pp. 31-33, 1998.
Ngo et al, 1994, Computational Complexity, Protein Structure Prediction, and the Levinthal Paradox; the Protein Folding Problem and Tertiary Structure Prediction, pp. 491-495, Birkhauser Boston.
Livnah et al, The Structure of the Complex Between Avidin and the Dye, 2-(4′-hydroxyazobenzene) benzoic acid (HABA), FEBS vol. 328 (1-2): 165-168, Elsevier Science Publishers BV, August 1993.
Bradley Arant Boult & Cummings LLP
Huynh Phuong
LandOfFree
Multidrug multiligand conjugates for targeted drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Multidrug multiligand conjugates for targeted drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Multidrug multiligand conjugates for targeted drug delivery will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4153954